040760 UK Health- and Pharmaceutical Economics (BA) (2018S)
Continuous assessment of course work
Labels
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from We 14.02.2018 09:00 to We 21.02.2018 12:00
- Deregistration possible until We 14.03.2018 23:59
Details
max. 30 participants
Language: German
Lecturers
Classes (iCal) - next class is marked with N
Friday
16.03.
13:15 - 18:15
Seminarraum 6 Oskar-Morgenstern-Platz 1 1.Stock
Saturday
17.03.
09:45 - 13:00
Seminarraum 6 Oskar-Morgenstern-Platz 1 1.Stock
Friday
20.04.
13:15 - 18:15
Seminarraum 5 Oskar-Morgenstern-Platz 1 1.Stock
Saturday
21.04.
09:45 - 13:00
Seminarraum 5 Oskar-Morgenstern-Platz 1 1.Stock
Friday
08.06.
13:15 - 16:30
Seminarraum 5 Oskar-Morgenstern-Platz 1 1.Stock
Saturday
09.06.
09:45 - 11:15
Hörsaal 5 Oskar-Morgenstern-Platz 1 Erdgeschoß
Information
Aims, contents and method of the course
Assessment and permitted materials
Minimum requirements and assessment criteria
Assigned Presentation (10 Min) 50%
Final Exam 50%
Final Exam 50%
Examination topics
Reading list
Association in the course directory
Last modified: Mo 07.09.2020 15:29
• Forms of Delivery of Medical Care
• Paying Providers
• Physicians as Suppliers of Medical Services
• Austrian Health Care System
Literature:
Breyer, F./Zweifel, P. Kifmann, M (2013), Gesundheitsökonomik, Springer. (Chapters 8, 10, 12)Part 2: Health Economic Evaluation
• Health Technology Assessment (HTA) across countries
• Cost Effectiveness analysis
• Cost utility analysis
• Cost benefit analysis
• Comparative effectiveness
• Decision analytic modeling (e.g. Markov Models)
• Evidenced based Medicine
Literature:
Drummond, M/Sculpher, M./Torrance, G./O’Brien, B./Stoddart, G. (2015), Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press (Chapters 5, 6, 7, 9)
Additional reading:
Schöffski, O. Graf v.d. Schulenburg, M. (Hg.) (2008), Gesundheitsökonomische Evaluationen, Springer.Part 3 Pharmaceutical Economics
• The pharmaceutical Industry
• Pharmaceutical R&D process
• Costs and returns on pharmaceutical R&D
• Pricing Pharmaceuticals
• Pharmaceutical Regulation (e.g. patent legislation)
• Drug MarketingLiterature:
Schweitzer, S. (2007), Pharmaceutical Economics and Policy, Oxford University Press. (Chapters 1, 4, 6, 8, 12)